| Product NDC: | 59148-013 |
| Proprietary Name: | ABILIFY |
| Non Proprietary Name: | ARIPIPRAZOLE |
| Active Ingredient(s): | 1 mg/mL & nbsp; ARIPIPRAZOLE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59148-013 |
| Labeler Name: | Otsuka America Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021713 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20041210 |
| Package NDC: | 59148-013-15 |
| Package Description: | 150 mL in 1 BOTTLE (59148-013-15) |
| NDC Code | 59148-013-15 |
| Proprietary Name | ABILIFY |
| Package Description | 150 mL in 1 BOTTLE (59148-013-15) |
| Product NDC | 59148-013 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ARIPIPRAZOLE |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20041210 |
| Marketing Category Name | NDA |
| Labeler Name | Otsuka America Pharmaceutical, Inc. |
| Substance Name | ARIPIPRAZOLE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |